PubMed · 432464
The source did not provide an abstract. Follow the original record for more information.
Explore connections, maps & timelines
J Lecomte, R Deroanne, A Cession-Fossion, J Juchmès. 1979-03-01. [Athletic performance and pharmacological doping].. https://pubmed.ncbi.nlm.nih.gov/432464/
Cite the original work for its findings. Save a collection to share your selection of sources.
KEEP EXPLORING
Mass spectrometry has become an invaluable tool for the identification of prohibited peptide hormones and proteins in doping control analysis. Regulatory authorities have established criteria for identifying banned drugs in doping control specimens, but these criteria do not address the specific issues for high molecular weight protein drugs such as molecular weight determination of multiply charged molecules, analysis of chemically or enzymatically derived degradation products, identification of amino acid sequence tags, etc. Technical considerations such as sample preparation methods (e.g. immunoaffinity purification), resulting analytes (e.g. intact compounds vs. chemically or enzymatically derived peptides), ionization modes, analyzer resolution, and the information provided by respective techniques are discussed in light of sports drug testing requirements using typical application examples.
Explore the source record for details and available documents.
Explore the source record for details and available documents.